AMICAR TAB 500MG DIN 00127671
Status: Cancelled Post Market
Holder: LEDERLE CYANAMID CANADA INC.
Molecule: EPSILON AMINOCAPROIC ACID
Health Canada record
| Active ingredient(s) | EPSILON AMINOCAPROIC ACID 500 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | B02AA01 AMINOCAPROIC ACID |
| Original market date | 31-Dec-1964 |
| Current status date | 14-Aug-1997 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing EPSILON AMINOCAPROIC ACID
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02171473 | AMICAR - SYR 250MG/ML | WYETH-AYERST CANADA INC. | Syrup | EPSILON AMINOCAPROIC ACID 250 MG | Cancelled Post Market |
| 02169754 | AMICAR - TAB, 500MG | WYETH CANADA | Tablet | EPSILON AMINOCAPROIC ACID 500 MG | Cancelled Post Market |
| 00127655 | AMICAR INJ 250MG/ML | LEDERLE CYANAMID CANADA INC. | Liquid | EPSILON AMINOCAPROIC ACID 250 MG | Cancelled Post Market |
| 02169746 | AMICAR INJECTION - LIQ IV 250MG/ML | WYETH CANADA | Liquid | EPSILON AMINOCAPROIC ACID 250 MG | Cancelled Post Market |
| 00127663 | AMICAR SYR 250MG/ML | LEDERLE CYANAMID CANADA INC. | Syrup | EPSILON AMINOCAPROIC ACID 250 MG | Cancelled Post Market |